Navigation Links
Pneumonia Vaccine Is Keeping Kids Healthier
Date:12/7/2007

New shot has cut hospitalizations by more than half, CDC study finds

FRIDAY, Dec. 7 (HealthDay News) -- Among children younger than 2, receiving the pneumococcal vaccine appears to be associated with fewer hospitalizations for pneumonia and reduced health-care expenses, according to a new report from the U.S. Centers for Disease Control and Prevention.

Beginning in 2000, the 7-valent pneumococcal conjugate vaccine (PDV7) became part of the routine immunization schedule for American children, according to background information in a news release about the study.

The vaccine -- which protects against pneumococcal pneumonia, caused by the Streptococcus pneumoniae bacteria -- is recommended for all children aged 2 months to 23 months and children aged 24 months to 59 months who are at increased risk for pneumococcal disease.

Between 2002 and 2005, the number of American children aged 19 months to 35 months receiving three or more doses of the PDV7 vaccine increased from 41 percent to 83 percent.

For this study, the CDC researchers analyzed 1997 to 2004 health records from a database of about 40 large U.S. employers. The findings are published in the December issue of the Archives of Pediatrics & Adolescent Medicine.

"Comparing the rates in 2004 with those in the baseline period of 1997 to 1999 among children younger than two years, hospitalizations due to all-cause pneumonia declined from 11.5 to 5.5 per 1,000 children (52.4 percent decline) and ambulatory (outpatient) visits due to all-cause pneumonia declined from 99.3 to 58.5 per 1,000 children (41.1 percent decline)," the study authors wrote.

"Rates of hospitalization due to pneumococcal pneumonia declined from 0.6 to 0.3 per 1,000 children (57.6 percent decline) and rates of ambulatory visits declined from 1.7 to 0.9 per 1,000 children (46.9 percent decline)," the authors added.

The findings add to growing evidence of the benefits of PCV7 vaccination and suggest the vaccine plays an important role in reducing pneumonia rates and health-care costs, the authors concluded.

More information

Visit the U.S. Centers for Disease Control and Prevention for more about child immunizations.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Dec. 3, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Zinc Helps Elderly Ward Off Pneumonia
2. Heart attacks/pneumonia falls short of national goals
3. Emergency Care for Heart Attacks, Pneumonia Fails to Meet Goals
4. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
5. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
6. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
7. Vaccine Stops Alzheimers Brain Tangles
8. Human Papilloma Virus vaccines may decrease chances of oral cancer
9. U.S. Teens Fall Short on Vaccine Coverage
10. Nasal Anthrax Vaccine Proves Effective in Animal Study
11. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... ... Center for Autism and Related Disorders (CARD) Portland today announced plans to host ... other developmental disabilities. The group, which is being launched with the help of Robbie ... share stories and advice, seek help, and continue their education on how to best ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a leading ... the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The ... education, experience, and professional associations. , One the most frequently honored surgeons ...
(Date:12/2/2016)... Cleveland, OH (PRWEB) , ... December 02, 2016 ... ... provider of veterinarian diagnostic imaging systems and the first company to ... Robot With a Heart at their tradeshow booth # 941 for the American ...
(Date:12/2/2016)... ... 02, 2016 , ... Clarify Health Solutions, Inc., the leading ... in an initial round of funding. The round was led by experienced investors ... receive far better care through the application of the best technologies from other ...
(Date:11/30/2016)... (PRWEB) , ... November 30, 2016 , ... ... to announce that we have been designated as a Cigna Infertility Center of ... exceed rigorous performance standards. , “It’s an honor to be designated a ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... - bioLytical lanza el INSTI HIV Self Test para el mercado ... Continue Reading ... New: INSTI Self Test! ... , bioLytical Laboratories (la "Compañía"), un líder mundial ... lanzamiento de su INSTI HIV Self Test  a África con una versión de ...
(Date:12/2/2016)... According to the latest market report published by ... Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type Segment Anticipated ... the global automated endoscope reprocessors market was valued at US$ 740.6 Mn ... of 7.2% during an eight-year forecast period 2016-2024, to reach ... ...
(Date:12/2/2016)... , Dec. 2, 2016 In the ... sources apart from those derived from C. sativa, the ... Universita` di Napoli Federico II , the Universita` ... the first comprehensive, critical, integrated and unified inventory of ... article focuses on the remarkable chemical and structural ...
Breaking Medicine Technology: